Aptose Biosciences To Host Conference Call and Webcast For Four Month Interim Period Ended September 30, 2014 Oct 30, 2014 7:01am EDT
Aptose Biosciences Announces Approval for Listing on the NASDAQ Capital Market Shares to Begin Trading Under the Symbol APTO Oct 21, 2014 8:00am EDT
Aptose Biosciences Joins The Leukemia & Lymphoma Society's Groundbreaking Beat AML Research Initiative with Oregon Health & Science University Sep 29, 2014 8:30am EDT
Aptose Biosciences Recruits Stephen B. Howell, M.D. to Act in the Capacity of Chief Medical Officer Sep 08, 2014 7:00am EDT
